• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The normal biodistribution of the short half life alpha radionuclide At-211 and the evaluation of thyroid cancer accumulation.

Research Project

Project/Area Number 15K09955
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Radiation science
Research InstitutionOsaka University

Principal Investigator

SHIMOSEGAWA EKU  大阪大学, 医学系研究科, 寄附講座教授 (30370258)

Co-Investigator(Kenkyū-buntansha) 池田 隼人  東北大学, サイクロトロン・ラジオアイソトープセンター, 助教 (30649083)
金井 泰和  大阪大学, 医学系研究科, 寄附講座助教 (60397643)
畑澤 順  大阪大学, 医学系研究科, 教授 (70198745)
渡部 直史  大阪大学, 医学系研究科, 助教 (90648932)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Keywordsアスタチン-211 / At-211 / 甲状腺摂取率 / α線 / アルファ線 / 甲状腺癌 / 内用療法 / 核医学治療 / I-123 / アスタチン / 胃摂取率 / 甲状腺
Outline of Final Research Achievements

The present study evaluated the distribution of At-211 by a daughter nuclide Po-211 imaging with gamma camera in normal rats, and revealed the physiological accumulation of At-211 of the thyroid gland and the stomach. We estimated thyroid and stomach uptake ratio of At-211 with comparing the difference between intravenous administration and oral intake. In addition, we evaluated At-211 accumulation in mice model of the thyroid cancer cell expressing the human Na/I symporter.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (5 results)

All 2017 2016

All Presentation (4 results) (of which Int'l Joint Research: 1 results) Patent(Industrial Property Rights) (1 results)

  • [Presentation] 健常ラットにおけるアスタチン211およびヨウ素123の甲状腺および胃への集積2016

    • Author(s)
      池田 隼人,渡辺 晋一郎,下瀬川 恵久,神谷 貴史,堀次 元気,髙橋 成人,篠原 厚,畑澤 順
    • Organizer
      第56回日本核医学会学術総会
    • Place of Presentation
      名古屋国際会議場
    • Year and Date
      2016-11-03
    • Related Report
      2016 Research-status Report
  • [Presentation] ガンマカメラによる正常ラットのアスタチン-211とヨウ素-123の甲状腺および胃への集積評価2016

    • Author(s)
      池田隼人,渡辺晋一郎,髙橋成人,篠原厚,下瀬川恵久,畑澤順
    • Organizer
      2016日本放射化学会年会 第60回放射化学討論会
    • Place of Presentation
      新潟大学五十嵐キャンパス・総合教育研究棟
    • Year and Date
      2016-09-10
    • Related Report
      2016 Research-status Report
  • [Presentation] Difference in thyroid uptake between Astatine-211 and Iodine-123 in normal rats: a comparative study between oral and intravenous administration.2016

    • Author(s)
      Shinichiro Watanabe, Hayato Ikeda, Eku Shimosegawa, Takashi Kamiya, Genki Horitsugi, Naruto Takahashi, Atsushi Shinohara, Jun Hatazawa.
    • Organizer
      SNMMI 2016 Annual Meeting
    • Place of Presentation
      San Diego Convention Center, Calfornia, USA
    • Year and Date
      2016-06-11
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research
  • [Presentation] 静脈投与または経口投与における正常ラットのアスタチン-211とヨウ素-123の甲状腺集積の比較2016

    • Author(s)
      池田 隼人,渡辺 晋一郎,下瀬川 恵久,畑澤 順
    • Organizer
      第53回腫瘍免疫核医学研究会
    • Place of Presentation
      大阪国際交流センター
    • Related Report
      2016 Research-status Report
  • [Patent(Industrial Property Rights)] [At-211]イオンを含有する組成物による甲状腺癌治療2017

    • Inventor(s)
      渡部直史、白神宜史、兼田加珠子、下瀬川恵久、篠原厚、畑澤順
    • Industrial Property Rights Holder
      大阪大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2017
    • Related Report
      2017 Annual Research Report

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi